|
1
|
Griffiths CEM, Armstrong AW, Gudjonsson JE
and Barker JNWN: Psoriasis. Lancet. 397:1301–1315. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Damiani G, Bragazzi NL, Karimkhani Aksut
C, Wu D, Alicandro G, McGonagle D, Guo C, Dellavalle R, Grada A,
Wong P, et al: The global, regional, and national burden of
psoriasis: Results and insights from the global burden of disease
2019 study. Front Med (Lausanne). 8(743180)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang M, Su W, Deng J, Zhai B, Zhu G, Gao
R, Zeng Q, Qiu J, Bian Z, Xiao H, et al: Multi-ancestry genome-wide
meta-analysis with 472,819 individuals identifies 32 novel risk
loci for psoriasis. J Transl Med. 23(133)2025.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Singh S, Pradhan D, Puri P, Ramesh V,
Aggarwal S, Nayek A and Jain AK: Genomic alterations driving
psoriasis pathogenesis. Gene. 683:61–71. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Brożyna AA, Slominski RM, Nedoszytko B,
Zmijewski MA and Slominski AT: Vitamin D signaling in psoriasis:
Pathogenesis and therapy. Int J Mol Sci. 23(8575)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gisondi P, Gracia-Cazaña T, Kurzen H and
Galván J: Calcipotriol/Betamethasone dipropionate for the treatment
of psoriasis: Mechanism of action and evidence of efficacy and
safety versus topical corticosteroids. J Clin Med.
13(4484)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Visconti B, Paolino G, Carotti S,
Pendolino AL, Morini S, Richetta AG and Calvieri S:
Immunohistochemical expression of VDR is associated with reduced
integrity of tight junction complex in psoriatic skin. J Eur Acad
Dermatol Venereol. 29:2038–2042. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liang W, Lin Z, Zhang L, Qin X, Zhang Y
and Sun L: Calcipotriol inhibits proliferation of human
keratinocytes by downregulating STAT1 and STAT3 signaling. J
Investig Med. 65:376–381. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cao M, Mei L, Xiao M, Li J and Fang F:
Calcipotriol inhibits psoriasis-like angiogenic features in
K14-VEGF transgenic mice. Eur J Dermatol. 32:24–33. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Slominski AT, Kim TK, Janjetovic Z,
Slominski RM, Li W, Jetten AM, Indra AK, Mason RS and Tuckey RC:
Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol
Metabolites in the Skin. J Invest Dermatol. 144:2145–2161.
2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang Y, Jing D, Zhou G, Xiao Y, Shen M,
Chen X and Liu H: Evidence of a causal relationship between vitamin
D status and risk of psoriasis from the UK Biobank study. Front
Nutr. 9(807344)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lee YH and Song GG: Association between
circulating 25-hydroxyvitamin D levels and psoriasis, and
correlation with disease severity: A meta-analysis. Clin Exp
Dermatol. 43:529–535. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Elmelid A, Siekkeri Vandikas M, Gillstedt
M, Osmancevic A and Alsterholm M: The effect of narrow-band
ultraviolet B phototherapy on free and total vitamin D serum levels
in mild to severe plaque psoriasis. Biomolecules.
13(1018)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Elgarhy LH, Eltatawy RA, Rizk O and Ismail
M: Vitamin D receptor expression in chronic plaque psoriasis before
and after narrowband ultraviolet B phototherapy. J Cutan Aesthet
Surg. 16:128–133. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lee YH: Vitamin D receptor ApaI, TaqI,
BsmI, and FokI polymorphisms and psoriasis susceptibility: An
updated meta-analysis. Clin Exp Dermatol. 44:498–505.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Agliardi C, Guerini FR, Bolognesi E,
Zanzottera M and Clerici M: VDR gene single nucleotide
polymorphisms and autoimmunity: A narrative review. Biology
(Basel). 12(916)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Poon AH, Gong L, Brasch-Andersen C,
Litonjua AA, Raby BA, Hamid Q, Laprise C, Weiss ST, Altman RB and
Klein TE: Very important pharmacogene summary for VDR.
Pharmacogenet Genomics. 22:758–763. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Uitterlinden AG, Fang Y, Van Meurs JB,
Pols HA and Van Leeuwen JP: Genetics and biology of vitamin D
receptor polymorphisms. Gene. 338:143–156. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Saccone D, Asani F and Bornman L:
Regulation of the vitamin D receptor gene by environment, genetics
and epigenetics. Gene. 561:171–180. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Andraos C, Koorsen G, Knight JC and
Bornman L: Vitamin D receptor gene methylation is associated with
ethnicity, tuberculosis, and TaqI polymorphism. Hum Immunol.
72:262–268. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Stefanic M, Rucevic I and Barisic-Drusko
V: Meta-analysis of vitamin D receptor polymorphisms and psoriasis
risk. Int J Dermatol. 52:705–710. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu JL, Zhang SQ and Zeng HM: ApaI, BsmI,
FokI and TaqI polymorphisms in the vitamin D receptor (VDR) gene
and the risk of psoriasis: A meta-analysis. J Eur Acad Dermatol
Venereol. 27:739–746. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee YH, Choi SJ, Ji JD and Song GG:
Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and
psoriasis susceptibility: A meta-analysis. Mol Biol Rep.
39:6471–6478. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
European Medicines Agency: Position paper
on terminology in pharmacogenetics. EMEA/CPMP/3070/01. EMEA,
London, 2002. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/position-paper-terminology-pharmacogenetics_en.pdf.
|
|
25
|
Strober B, Ryan C, van de Kerkhof P, van
der Walt J, Kimball AB, Barker J and Blauvelt A: International
Psoriasis Council Board Members and Councilors. Recategorization of
psoriasis severity: Delphi consensus from the International
Psoriasis Council. J Am Acad Dermatol. 82:117–122. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
AbdElneam AI, Al-Dhubaibi MS, Bahaj SS and
Mohammed GF: The vitamin D receptor gene polymorphism rs1544410 T/T
genotype as a predictor of factor vitamin D thresholds deficiency
in patients with psoriasis vulgaris-A preliminary study. J Cosmet
Dermatol. 22:1642–1646. 2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Saeki H, Asano N, Tsunemi Y, Takekoshi T,
Kishimoto M, Mitsui H, Tada Y, Torii H, Komine M, Asahina A and
Tamaki K: Polymorphisms of vitamin D receptor gene in Japanese
patients with psoriasis vulgaris. J Dermatol Sci. 30:167–171.
2002.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li J, Sun L, Sun J and Yan M: Pooling
analysis regarding the impact of human vitamin D receptor variants
on the odds of psoriasis. BMC Med Genet. 20(161)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
A Anani HA, Khalifa WA, Althoqapy AA,
Maklad SS, Kamal H, Sabry D and Samir M: Frequency of genotypes and
allelic polymorphisms of vitamin D receptor in egyptian psoriatic
patients and their association with disease severity, immune
modulation of IL-22 levels and the response to topical calcipotriol
treatment: A case control study. Indian J Dermatol. 67:37–44.
2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu J, Wang W, Liu K, Wan D, Wu Z, Cao Z,
Luo Y, Xiao C and Yin M: Vitamin D receptor gene polymorphisms are
associated with psoriasis susceptibility and the clinical response
to calcipotriol in psoriatic patients. Exp Dermatol. 29:1186–1190.
2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rucevic I, Stefanic M, Tokic S, Vuksic M,
Glavas-Obrovac L and Barisic-Drusko V: Lack of association of
vitamin D receptor gene 3'-haplotypes with psoriasis in Croatian
patients. J Dermatol. 39:58–62. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Polić MV, Rucević I, Barisić-Drusko V,
Miskulin M, Glavas-Obrovac L, Stefanić M, Karner I, Lipozencić J,
Bacun T and Mihaljević I: Polymorphisms of vitamin D receptor gene
in the population of eastern Croatia with psoriasis vulgaris and
diabetes mellitus. Coll Antropol. 36:451–457. 2012.PubMed/NCBI
|
|
33
|
Zuel-Fakkar NM, Kamel MM, Asaad MK, Mahran
MZ and Shehab AA: A study of ApaI and TaqI genotypes of the vitamin
D receptor in Egyptian patients with psoriasis. Clin Exp Dermatol.
36:355–359. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Halsall JA, Osborne JE, Pringle JH and
Hutchinson PE: Vitamin D receptor gene polymorphisms, particularly
the novel A-1012G promoter polymorphism, are associated with
vitamin D3 responsiveness and non-familial susceptibility in
psoriasis. Pharmacogenet Genomics. 15:349–355. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Richetta AG, Silvestri V, Giancristoforo
S, Rizzolo P, D'Epiro S, Graziano V, Mattozzi C, Navazio AS,
Campoli M, D'Amico C, et al: A-1012G promoter polymorphism of
vitamin D receptor gene is associated with psoriasis risk and lower
allele-specific expression. DNA Cell Biol. 33:102–109.
2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou X, Xu LD and Li YZ: The association
of polymorphisms of the vitamin D receptor gene with psoriasis in
the Han population of northeastern China. J Dermatol Sci. 73:63–66.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Acikbas I, Sanlı B, Tepeli E, Ergin S,
Aktan S and Bagci H: Vitamin D receptor gene polymorphisms and
haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis
patients. Med Sci Monit. 18:CR661–6. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ruggiero M, Gulisano M, Peruzzi B, Giomi
B, Caproni M, Fabbri P and Pacini S: Vitamin D receptor gene
polymorphism is not associated with psoriasis in the Italian
Caucasian population. J Dermatol Sci. 35:68–70. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Okita H, Ohtsuka T, Yamakage A and
Yamazaki S: Polymorphism of the vitamin D(3) receptor in patients
with psoriasis. Arch Dermatol Res. 294:159–162. 2002.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Park BS, Park JS, Lee DY, Youn JI and Kim
IG: Vitamin D receptor polymorphism is associated with psoriasis. J
Invest Dermatol. 112:113–116. 1999.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mee JB and Cork MJ: Vitamin D receptor
polymorphism and calcipotriol response in patients with psoriasis.
J Invest Dermatol. 110:301–302. 1998.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kontula K, Välimäki S, Kainulainen K,
Viitanen AM and Keski-Oja J: Vitamin D receptor polymorphism and
treatment of psoriasis with calcipotriol. Br J Dermatol.
136:977–978. 1997.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ohata C, Anezaki H, Kaneko S, Okazaki F,
Ito K, Matsuzaka Y, Kikuchi S, Koike Y, Murota H, Miyagi T, et al:
Clinical characteristics of patients with psoriasis with family
history: A multicenter observational study. J Dermatol. 50:746–752.
2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Dayangac-Erden D, Karaduman A and
Erdem-Yurter H: Polymorphisms of vitamin D receptor gene in Turkish
familial psoriasis patients. Arch Dermatol Res. 299:487–491.
2007.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Neves JSF, Visentainer JEL, Reis DMDS,
Rocha Loures MA, Alves HV, Lara-Armi FF, de Alencar JB, Valentin
Zacarias JM and Sell AM: The Influence of Vitamin D Receptor Gene
Polymorphisms in Spondyloarthritis. Int J Inflam.
2020(8880879)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Langenbruch A, Radtke MA, Krensel M,
Jacobi A, Reich K and Augustin M: Nail involvement as a predictor
of concomitant psoriatic arthritis in patients with psoriasis. Br J
Dermatol. 171:1123–1128. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Stuart PE, Nair RP, Tsoi LC, Tejasvi T,
Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R,
et al: Genome-wide association analysis of psoriatic arthritis and
cutaneous psoriasis reveals differences in their genetic
architecture. Am J Hum Genet. 97:816–836. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Meyer V, Saccone DS, Tugizimana F, Asani
FF, Jeffery TJ and Bornman L: Methylation of the vitamin D receptor
(VDR) Gene, together with genetic variation, race, and environment
influence the signaling efficacy of the toll-like receptor 2/1-VDR
pathway. Front Immunol. 8(1048)2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Stratigos AJ, Richard MA, Dessinioti C,
Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Trakatelli M,
Puig L, et al: The prevalence of skin diseases in Greece, impact on
quality of life and stigmatization: A population-based survey
study. JEADV Clin Pract. 3:591–599. 2024.
|
|
50
|
Visscher PM, Wray NR, Zhang Q, Sklar P,
McCarthy MI, Brown MA and Yang J: 10 Years of GWAS discovery:
Biology, function, and translation. Am J Hum Genet. 101:5–22.
2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Manolio TA, Collins FS, Cox NJ, Goldstein
DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR,
Chakravarti A, et al: Finding the missing heritability of complex
diseases. Nature. 461:747–753. 2009.PubMed/NCBI View Article : Google Scholar
|
